Effect of Virechana, basti and Taila pana in the treatment of Paralysis(Hemiplegia)

A Comparative study of Virechana Karma, Kaala-Basti and Karpasasthyadi Taila Pana in the management of Pakshaghata (Hemiplegia): An Open labelled randomized comparative clinical trial - PKGT

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/01/011406

Enrollment

Registered

2018-01-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I639- Cerebral infarction, unspecified Health Condition 2: null- Patient diagnosed with Pakshaghata (Hemiplegia)

Interventions

Intervention1: Kapasasthyadi Kaala Basti: Patients registered under this group shall be administered Kaala-Basti (sixteen days) using Karpasasthyadi tail (100ml) for Anuvasana and Niruha (600ml) using

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed as Pakshaghata (CVAwith hemiplegia) Patients who are yogya for Virechana karma, Basti karma and Snehpana Age group of 20-60 yrs will be selected Mild to moderate hypertensive shall be considered Chronicity limits below 1 yr

Exclusion criteria

Exclusion criteria: Patients of Intracranial infection Degenerative lesions Intracranial space occupying lesions and trauma Patients with altered sensorium

Design outcomes

Primary

Measure	Time frame
relief in signs and symptoms of Pakshaghata (Hemiplegia)Timepoint: 21 days	—

Secondary

Measure	Time frame
Improvement in Quality of Life of PatientTimepoint: 21 days	—

Countries

India

Contacts

Public ContactProf Anup B Thakar

Institute For Post Graduate Teaching And Research In Ayurveda Gujarat Ayurved University

anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026